As infectious diseases such as the Zika virus continue to threaten public health, it’s essential that you, as a vaccine developer, work closely with a laboratory partner in order to avoid challenges along the drug development continuum.
Download our new insight brief, Zika Vaccine Research: Complex Steps toward a Critical Need
, to discover 5 key questions that should be asked prior to beginning your vaccine study, concerning:
- Vaccine immunogenicity
- Exposure to related viruses
Solutions has a geographic footprint, scientific and therapeutic expertise, and deep understanding of global, regional and local requirements for vaccine and anti-infective clinical trials. Learn more
about how we can be your trusted partner for vaccine development.